Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Chiral Amine. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN110577941A reveals mutated amine dehydrogenase for asymmetric reductive amination. Enables cost reduction in pharmaceutical intermediates manufacturing with high optical purity.
Patent CN112608274A reveals a novel Pd-catalyzed route for chiral amines. Discover cost reduction in chiral amine manufacturing and scalable supply chain solutions.
Patent CN103012498A reveals high-efficiency Ir-catalysts for ketone reduction, offering scalable routes for chiral pharmaceutical intermediates.
Patent CN102372642A details a safe, scalable route for (1S)-4,5-dimethoxy-1-[(methylamino)methyl]benzocyclobutane, replacing hazardous LiAlH4 with mild borohydride reduction for cost-effective manufacturing.
Novel one-step route to 4-fluorobenzoic acid-(R)-phenylethylamine salt using Cu-catalyst. Offers simplified processing for high-purity chiral intermediates.
Patent CN1566084A reveals novel water-soluble diamines enabling green asymmetric hydrogenation. Discover cost-effective API intermediate manufacturing solutions.
Patent CN1328230C details asymmetric transfer hydrogenation of imines using Rh/Ru/Ir catalysts for high-purity pharmaceutical intermediates.
Patent CN109111380B introduces a transition-metal-free method for synthesizing chiral amines via hydrogen borrowing, offering cost reduction in API manufacturing and high stereoselectivity.
Novel one-step synthesis of chiral oxazolines using ZnCl2 offers high purity and cost efficiency for asymmetric catalysis applications in drug discovery.
Patent CN102382138B details a robust two-step synthesis for chiral phosphoramides. Discover cost-effective manufacturing routes for asymmetric catalysis intermediates.
Novel Pd/C catalytic method ensures high purity and yield. Reduces steps for pharmaceutical intermediate manufacturing. Reliable supply chain partner.
Patent CN121135789A reveals a novel supramolecular catalytic route for chiral Ugi amine. Achieve 99% ee and 99% yield with scalable, cost-effective manufacturing for global supply chains.
Discover the patented process for diastereomerically enriched compounds. Enhance supply chain reliability and reduce manufacturing costs with scalable pharma intermediates.
Patent CN113461589A details a novel one-step asymmetric Friedel-Crafts reaction yielding high-purity chiral indoleamines with significant cost reduction potential.
Patent CN105112468A reveals multi-enzyme systems for chiral amine synthesis. Achieve high purity and cost reduction in pharmaceutical intermediate manufacturing with scalable biocatalysis.
Patent CN110551771B details a green enzymatic route for chiral 3-amino-1-butanol. Discover cost-effective, high-purity pharmaceutical intermediate manufacturing solutions.
Patent CN113150031A discloses a novel oxaspiro chiral phosphoric acid enabling >97% ee in asymmetric synthesis. Reliable supplier for high-purity pharmaceutical intermediates.
Patent CN103360341B reveals novel tert-leucine derivatives enabling high-selectivity organocatalysis. This technology offers significant cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Novel enzymatic synthesis method for high-purity chiral cis-cyclohexanediamine. Scalable process reduces impurities and ensures supply chain reliability for anticoagulant manufacturing.
Patent CN110862324A discloses a novel iridium-catalyzed asymmetric reductive amination method achieving up to 95% ee for key pharmaceutical intermediates like Cinacalcet.